Public Release: 

Sharing of research data and findings should be the norm in public health emergencies

PLOS

Opting in to data sharing should be the default practice during public health emergencies, such as the recent Ebola epidemic, and barriers to sharing data and findings should be removed to ensure those responding to the emergency have the best available evidence at hand according to Vasee Moorthy and colleagues from the World Health Organization (WHO) in a Policy Forum article published in PLOS Medicine.

In their article the authors outline the findings of a recent WHO-organized consultation that was attended by leading representatives from the scientific community, biomedical journals, industry, funding organizations, and government ministries. Meeting participants collectively identified several key obstacles to sharing research data and findings in times of acute public health need. These included the misperception that disclosure of major findings may negatively prejudice subsequent journal publication; limitations in technical capacity to share information; concerns that data would be analysed and published without due recognition; and the possibility that data sharing could lead to the development of products that source populations are unable to afford.

During the meeting representatives from leading biomedical journals responded with an unequivocal assertion that public disclosure of information of relevance to public health emergencies should not prejudice journal publication of full scientific reports. Meeting participants also recognized that it is not enough for parties to simply agree, in principle, on sharing primary data, as the world must also commit to tackling the technical challenges of implementing data sharing agreements by simplifying and standardizing data capture procedures, assuring data quality, and harmonizing disparate data platforms. How best to effect a shift away from the culture of data ownership toward one of data stewardship remains paramount among broader issues to be addressed.

The authors conclude, "[a]s the quick and transparent dissemination of information is the bedrock of good science and public health practice, it is important that the current trends in data sharing carry over to all matters of acute public health need. Such a global norm would advance the spirit of open collaboration, simplify current mechanisms of information sharing, and potentially save many lives in subsequent outbreaks."

In an accompanying Perspective article Patrick Vallance and colleagues from GlaxoSmithKline note, "[w]e are perpetually in the midst of several health care crises, including those of neglected tropical diseases and other chronic diseases, for which data sharing has the potential to lead to faster and better solutions. As a matter of principle, we should be willing to share data without regards to which disease is being studied."

###

FROM THE PLOS MEDICINE MAGAZINE:

Vasee Moorthy and colleagues

Funding: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Wellcome Trust contributed towards the cost of the consultation.

Competing Interests: The authors have declared that no competing interests exist.

Citation: Modjarrad K, Moorthy VS, Millett P, Gsell PS, Roth C, Kieny M-P (2016) Developing Global Norms for Sharing Data and Results during Public Health Emergencies. PLoS Med 13(1): e1001935.doi:10.1371/journal.pmed.1001935

Author Affiliations:

World Health Organization, Geneva, Switzerland

IN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER:

http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001935

Contact:

Vasee Moorthy
moorthyv@who.in
World Health Organization, Geneva, Switzerland

Patrick Vallance and colleagues

Funding: There was no specific funding to support this work.

Competing Interests: We have read the journal's policy and have the following conflicts: PV is a President at GlaxoSmithKline and holds stock or stock options in GlaxoSmithKline. AF is Head of Medical Policy at GlaxoSmithKline and holds stock or stock options in GlaxoSmithKline. MS is Chief Medical Officer at GlaxoSmithKline and holds stock or stock options in GlaxoSmithKline. PV is a member of the Editorial Board of PLOS Medicine.

Citation: Vallance P, Freeman A, Stewart M (2016) Data Sharing as Part of the Normal Scientific Process: A View from the Pharmaceutical Industry. PLoS Med 13(1): e1001936. doi:10.1371/journal.pmed.1001936

Author Affiliations:

GlaxoSmithKline, Brentford, Middlesex, United Kingdom;

GlaxoSmithKline, Collegeville, Pennsylvania, United States of America

IN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER:

http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001936

Contact:

Patrick Vallance
patrick.5.vallance@gsk.com
GlaxoSmithKline, United Kingdom,

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.